Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT00699036 · UNKNOWN

Trial details

NCT number: NCT00699036
Sponsor: Brooke Army Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis Nonalcoholic Fatty Liver Disease

Start date: 2007-04-01
Primary completion: 2009-07-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.